Targeted EGFR Antisense Gene Therapy for Brain Cancer

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43CA109782-01
Agency Tracking Number: CA109782
Amount: $589,796.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
ARMAGEN TECHNOLOGIES, INC., 914 COLORADO BLVD, SANTA MONICA, CA, 90401
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 RUBEN Boado
 () -
Business Contact
 RUBEN BOADO
Phone: (310) 917-1275
Email: RBOADO@NEUROGENETECH.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The incidence of brain cancer in the U.S. is surprisingly high, and includes 15,000 new cases per year of the highly malignant primary brain cancer, glioblastoma multiforme (GBM), and about 150,000 cases per year of me

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government